Press Releases
Our press releases
- Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market Jan 18 2019
- Bio-Path Holdings Announces 1-for-20 Reverse Stock Split Jan 18 2019
- Bio-Path Holdings, Inc. Announces Closing of Public Offering of Common Stock Jan 17 2019
- Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock (Pricing) Jan 15 2019
- Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock (Launch) Jan 15 2019
- Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook Dec 27 2018
- Bio-Path Holdings Presents Interim Data from Phase 2 Study Evaluating Prexigebersen as a Treatment for Acute Myeloid Leukemia at the 60th Annual American Society of Hematology Annual Meeting Dec 3 2018
- BIO-PATH HOLDINGS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS Nov 15 2018
- Bio-Path Holdings to Announce Third Quarter 2018 Financial Results on November 15, 2018 Nov 8 2018
- Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting Nov 1 2018
Show More Posts
Loading...